Clinical Study
Therapeutic Efficacy of pH-Dependent Release Formulation of Mesalazine on Active Ulcerative Colitis Resistant to Time-Dependent Release Formulation: Analysis of Fecal Calprotectin Concentration
Figure 1
Results of retrospective study. (a) Changes in clinical activity index. (b) Clinical assessments at 8 weeks. .
(a) |
(b) |